C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability
Open Access
- 15 March 2005
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 105 (6) , 2350-2355
- https://doi.org/10.1182/blood-2004-05-1963
Abstract
Gram-negative bacterial endotoxemia may lead to the pathological increase of vascular permeability with systemic vascular collapse, a vascular leak syndrome, multiple organ failure (MOF), and/or shock. Previous studies demonstrated that C1 inhibitor (C1INH) protects mice from lipopolysaccharide (LPS)–induced lethal septic shock via a direct interaction with LPS. Here, we report that C1INH blocked the LPS-induced increase in transendothelial flux through an endothelial monolayer. In addition, LPS-mediated detachment of cultured endothelial cells was prevented with C1INH. C1INH also inhibited LPS-induced endothelial cell apoptosis as demonstrated by suppression of DNA fragmentation and annexin V expression. As illustrated by laser scanning confocal microscopy, C1INH completely blocked the binding of fluorescein isothiocyanate (FITC)–LPS to human umbilical vein endothelial cells (HUVECs). C1INH protected from localized LPS-induced increased plasma leakage in C57BL/6J mice and in C1INH-deficient mice. Local vascular permeability in response to LPS was increased to a greater extent in C1INH-deficient mice compared with wild-type littermate controls and was reversed by treatment with C1INH. Systemic administration of LPS to mice resulted in increased vascular permeability, which was reduced by C1INH. Therefore, these studies demonstrate that C1INH, in addition to its role in suppression of LPS-mediated macrophage activation, may play an important role in the prevention of LPS-mediated increased vascular permeability, endothelial cell injury, and multiple organ failure.Keywords
This publication has 38 references indexed in Scilit:
- N-Linked Glycosylation Is Required for C1 Inhibitor-Mediated Protection from Endotoxin Shock in MiceInfection and Immunity, 2004
- A Constitutive Cytoprotective Pathway Protects Endothelial Cells from Lipopolysaccharide-induced ApoptosisPublished by Elsevier ,2001
- Bacterial Lipopolysaccharide Disrupts Endothelial Monolayer Integrity and Survival Signaling Events through Caspase Cleavage of Adherens Junction ProteinsJournal of Biological Chemistry, 1998
- The Influence of C1-Esterase Inhibitor Substitution on Coagulation and Cardiorespiratory Parameters in an Endotoxin-Induced Rabbit Model of HypercoagulabilitySeminars in Thrombosis and Hemostasis, 1996
- Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activitiesClinical and Experimental Immunology, 1994
- Bacterial lipopolysaccharide induces actin reorganization, intercellular gap formation, and endothelial barrier dysfunction in pulmonary vascular endothelial cells: Concurrent F‐actin depolymerization and new actin synthesisJournal of Cellular Physiology, 1993
- Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor.Journal of Clinical Investigation, 1993
- C1-inhibitor concentrate for sepsis-related capillary leak syndromeThe Lancet, 1992
- Proteolytic inactivation of plasma C1- inhibitor in sepsis.Journal of Clinical Investigation, 1989
- Detection of active kallikrein in induced blister fluids of hereditary angioedema patients.The Journal of Experimental Medicine, 1980